These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1823214)

  • 1. The antiadrenergic effects of hypermagnesemia: an experimental study.
    Barros LF; Pileggi F
    Braz J Med Biol Res; 1991; 24(1):29-33. PubMed ID: 1823214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog.
    Friedman HS; Nguyen TN; Mokraoui AM; Barbour RL; Murakawa T; Altura BM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):126-30. PubMed ID: 3668845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hemodynamic effects of intravenous norepinephrine versus epinephrine and phenylephrine in patients with ischemic heart disease.
    Baraka A; Haroun S; Baroody MA; Sibai A; Dabbous A; el-Siddik S; Karam R
    Middle East J Anaesthesiol; 1991 Feb; 11(1):53-62. PubMed ID: 2067505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
    Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular fibrillation in acute experimental myocardial ischemia: protection by magnesium sulfate.
    Barros LF; Da-Luz PL; Silveira MC; Chagas AC; Pileggi F
    Braz J Med Biol Res; 1988; 21(4):791-9. PubMed ID: 3240378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors contributing to blood pressure elevation during norepinephrine and phenylephrine infusions in dogs.
    Stokland O; Thorvaldson J; Ilebekk A; Kiil F
    Acta Physiol Scand; 1983 Apr; 117(4):481-9. PubMed ID: 6136153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pretreatment with propranolol on potassium, calcium, and magnesium shifts after ventricular fibrillation in dogs.
    Salerno DM; Murakami M; Elsperger KJ
    J Lab Clin Med; 1989 Nov; 114(5):595-603. PubMed ID: 2809400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and electrocardiographic effects of magnesium sulfate in healthy dogs.
    Nakayama T; Nakayama H; Miyamoto M; Hamlin RL
    J Vet Intern Med; 1999; 13(5):485-90. PubMed ID: 10499734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
    Woodman OL; Vatner SF
    J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
    Trimarco B; Cuocolo A; Ricciardelli B; Patrignani P; Volpe M; de Luca N; Condorelli M
    J Pharmacol Exp Ther; 1986 May; 237(2):589-99. PubMed ID: 3084760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of arotinolol in anesthetized dogs and its affinities for adrenoceptors in vitro.
    Hashimoto H; Asano M; Hayashi T; Oguro K; Takiguchi Y; Nakashima M
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):23-34. PubMed ID: 6202253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular effect of a novel substance, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl] ethyl]-2,4 (1H, 3H)-quinazolinedione monohydrochloride (SGB 1534)].
    Uchida Y; Sugimoto T
    Nihon Yakurigaku Zasshi; 1985 Jun; 85(6):447-51. PubMed ID: 2863201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative hemodynamic effects of isoproterenol in chronically instrumented puppies and adult dogs.
    Driscoll DJ; Fukushige J; Hartley CJ; Lewis RM; Entman ML
    Dev Pharmacol Ther; 1981; 2(2):91-103. PubMed ID: 7472110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo interaction of AR-L 115BS (Vardax) with the adrenergic nervous system.
    Petein M; Pierpont GL; Francis GS; Cohn JN; From AH
    J Cardiovasc Pharmacol; 1984; 6(6):1020-6. PubMed ID: 6084757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course and hemodynamic effects of alpha-1-adrenergic bolus administration in anesthetized patients with myocardial disease.
    Schwinn DA; Reves JG
    Anesth Analg; 1989 May; 68(5):571-8. PubMed ID: 2541637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
    Imai N; Liang CS; Stone CK; Hayes JS; Hood WB
    J Pharmacol Exp Ther; 1987 Apr; 241(1):20-6. PubMed ID: 3572783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamics and blood flow distribution in experimental shock. The effect of noradrenaline and isoproterenol.
    Dedichen H
    J Oslo City Hosp; 1989 Mar; 39(3):23-9. PubMed ID: 2723876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.